TSRC, Tob. Sci. Res. Conf., 2023, 76, abstr. 04 (Symposium Harm Reduction) Global harm reduction regulation and research opportunities KOVACEVIC P. Cryomass Technologies Inc. Abstract not available....
46th TWC, Tob. Work. Conf., 2014, abstr. 62 Tobacco as a platform for foliar biosynthesis of advanced hydrocarbon fuels CHAMBERS O.; MANSSON C.; MELIS A.; LEMAUX P.; NIYOGI K.; WEMMER D.; KERFELD C.; YUAN L.; MUNDELL R. University of Kentucky, Lawrence Berkley National Laboratory, University of California, USA Reference only. Abstract submission was on a voluntary basis....
Bull. ARN, 2000, p. 44-57., ISSN.1146-6200. (-)-nicotine but not (-)-cotinine protects dopaminergic neurons from neurodegeneration in Parkinsonian syndroms PARAIN K.; HIRSCH E. INSERM U289, Hôpital de la Salpétrière, Paris, France Epidemiological studies show a lower incidence of Parkinson's disease for smokers than for non smokers, suggesting that a component in cigarette smoke protects dopaminergic neurons against nigrostriatal degeneration. In the present study we examined...
Bull. ARN, 1998, p. 16-29., ISSN.1146-6200 Physiopathology of Parkinson's disease, cigarette and nicotine HIRSCH E.C. INSERM U289, Hôpital de la Salpétrière, Paris, France The Parkinson's disease is a degenerative disease of the central nervous system which is characterised by a slow and progressive neuronal loss, the origin of which is still unknown. From a clinical point of view, this disease is defined by a lack of...